Rongjun Chen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rongjun chen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rongjun Chen Today - Breaking & Trending Today

Nanocapsules could reduce blood clot drug side effects

Researchers at Imperial College London have designed drug delivery nanocapsules that could reduce side effects of a major blood clot dissolving drug. ....

City Of , United Kingdom , Narupon Promvichai , Xiao Yun Xu , Rongjun Chen , Imperial Department Of Chemical Engineering , Researchers At Imperial College London , Imperial College London , Chemical Engineering , Imperial Department , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , கிஷியஓ யுன் ஐயூ , ஏகாதிபத்தியம் துறை ஆஃப் இரசாயன பொறியியல் , ஆராய்ச்சியாளர்கள் இல் ஏகாதிபத்தியம் கல்லூரி லண்டன் , ஏகாதிபத்தியம் கல்லூரி லண்டன் , இரசாயன பொறியியல் , ஏகாதிபத்தியம் துறை ,

Drug delivery nanocapsules could reduce existing treatment's side effects

Imperial scientists have designed drug delivery nanocapsules that could reduce the side effects of a major blood clot dissolving drug. ....

City Of , United Kingdom , Xiao Yun Xu , Rongjun Chen , Imperial Department Of Chemical Engineering , Imperial College London , Chemical Engineering , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , கிஷியஓ யுன் ஐயூ , ஏகாதிபத்தியம் துறை ஆஃப் இரசாயன பொறியியல் , ஏகாதிபத்தியம் கல்லூரி லண்டன் , இரசாயன பொறியியல் ,

Blood clot-busting nanocapsules could reduce existing treatment's side effects

Date Time
Blood clot-busting nanocapsules could reduce existing treatment’s side effects
Imperial researchers have designed drug delivery nanocapsules that could reduce the side effects of a major blood clot dissolving drug.
Tested on human blood in the lab, the selective nanocapsules could reduce the side effects of a major blood clot dissolving drug, which include bleeding on the brain. If confirmed with animal tests, the nanocapsules could also make the drug more effective at lower doses.
We have wrapped (the drug) in a package that extends this therapeutic window and minimises the required dose. Our results are exciting but animal and clinical studies are required for validation. Dr Rongjun Chen Department of Chemical Engineering ....

City Of , United Kingdom , Xiao Yun Xu , Simon Thom , Rongjun Chen , Dr Rongjun Chen Department Of Chemical Engineering , Imperial National Heart , Lung Institute , Imperial Department Of Chemical Engineering , Imperial College Healthcare , Professor Simon Thom National Heart , Sciences Research Council , Imperial Biomedical Research Centre , National Institute For Health Research , Imperial College London , Department Of Health , Chemical Engineering , Professor Simon Thom , National Heart , National Institute , Health Research , Social Care , Physical Sciences Research Council , Department Of Health , Science Advances , Research Council ,

Fact Check-SM-102 lipid in Moderna COVID-19 vaccine is not harmful

7 Min Read
The safety fact sheet that social media users are sharing as alleged proof of the harmful nature of the lipid SM-102 in the Moderna COVID-19 vaccine, is actually describing the dangers of chloroform. The fact sheet is for SM-102 supplied by biotechnology company Cayman Chemical as a solution in chloroform, meaning it is made up of 90% chloroform and 10% SM-102, where chloroform is listed as the only dangerous component.
The posts (here , here , here , here) display a video or screenshots indicating that SM-102 is an ingredient in the Moderna COVID-19 vaccine, followed by a Cayman Chemical (www.caymanchem.com/about) product information page for “SM-102”, visible here , and the safety fact sheet for that product, seen here . Users highlight that these pages say the product is “not for human or veterinary use”, “flammable”, “fatal in contact with skin”, “suspected of causing cancer” and more. ....

City Of , United Kingdom , Rongjun Chen , Thomson Reuters Trust Principles , Science Media Center , Department Of Chemical Engineering , Drug Administration , Neither The National Institute For Occupational Safety , European Chemicals Agency , Imperial College London , Reuters Fact , Cayman Chemical , Emergency Use Authorization , National Institute , Occupational Safety , Toxic Effects , Chemical Substances , Labelling Inventory , Biomaterials Engineering , Chemical Engineering , Reuters Fact Check , Thomson Reuters Trust , Sm102 Moderna , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை ப்ரிந்ஸிபல்ஸ் ,